Neuroone Medical Technologies (NMTC) Gross Profit (2011 - 2026)

Neuroone Medical Technologies has disclosed Gross Profit across 11 years of filings, most recently posting $990264.0 for Q1 2026.

• Quarterly Gross Profit rose 28.43% year-over-year to $990264.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.0 million (up 60.26% YoY) and the FY2025 annual result came in at $5.1 million, up 376.2% from the prior year.
• Gross Profit retreated to $990264.0 in Q1 2026, from $1.6 million in the prior quarter.
• Across five years, Gross Profit topped out at $1.9 million in Q4 2024 and bottomed at -$36223.0 in Q1 2022.
• The 5-year median for Gross Profit is $266314.0 (2023), against an average of $539881.4.
• Year-over-year, Gross Profit sank 71.49% in 2022 and jumped 3899.56% in 2023.
• Neuroone Medical Technologies' Gross Profit stood at -$12307.0 in 2022, then jumped by 2263.92% to $266314.0 in 2023, then soared by 623.54% to $1.9 million in 2024, then declined by 18.63% to $1.6 million in 2025, then tumbled by 36.84% to $990264.0 in 2026.
• According to Business Quant data, Gross Profit over the past three periods registered $990264.0, $1.6 million, and $1.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.